Resum
The efficacy of thrombolysis in clinical stroke subtypes is unclear. We compared the benefit of intravenous rt-PA in 11 patients with lacunar syndrome with that in 33 patients with a non-lacunar syndrome. Patients were matched by NIHSS score and time to treatment. Although no statistically significant differences were detected in outcome, the benefit was greater in the non-lacunar syndrome group. Copyright © 2006 S. Karger AG.
Idioma original | Anglès |
---|---|
Pàgines (de-a) | 70-73 |
Revista | European Neurology |
Volum | 55 |
Número | 2 |
DOIs | |
Estat de la publicació | Publicada - 1 de maig 2006 |